Financhill
Back

Coherus Oncology, Inc. Stock Predictions

Coherus Oncology, Inc. Stock Forecast

  • Is Coherus Oncology, Inc. Stock Undervalued?
    The current Coherus Oncology, Inc. [CHRS] share price is $1.67. The Score for CHRS is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • CHRS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Coherus Oncology, Inc. Stock Go Up Next Year?

Data Unavailable

Coherus Oncology, Inc. Stock Rating

Data Unavailable

Coherus Oncology, Inc. Stock Price History

Is CHRS stock going to rise?

  • The current trend is relatively stagnant and CHRS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
coherus.com

52-Week Data

52-Week High:
2.62
52-Week Low:
0.71

Prediction Charts

Market Cap:
251.1M
Price in USD:
1.67
Volume:
734K
Beta:
1.42

Technical Analysis

SMA50:
1.83
SMA100:
1.60
SMA200:
1.42
52-Wk Change:
103.29%

Stock Predictions

  • Is Coherus Oncology, Inc. stock public?
    Yes, Coherus Oncology, Inc. is a publicly traded company.
  • What is the Coherus Oncology, Inc. stock quote today?
    The Coherus Oncology, Inc. stock price is 1.67 USD today.
  • How to buy Coherus Oncology, Inc. stock online?
    You can buy Coherus Oncology, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-18 1.65 1.58 1.66 1.57
Mar-19 1.57 1.61 1.63 1.54
Mar-20 1.63 1.52 1.63 1.52
Mar-23 1.56 1.64 1.65 1.54
Mar-24 1.62 1.71 1.75 1.61
Mar-25 1.73 1.77 1.85 1.69
Mar-26 1.74 1.66 1.78 1.66
Mar-27 1.63 1.63 1.68 1.62
Mar-30 1.65 1.60 1.68 1.58
Mar-31 1.64 1.69 1.73 1.63
Apr-1 1.72 1.74 1.79 1.70
Apr-2 1.70 1.73 1.76 1.68
Apr-6 1.73 1.67 1.79 1.66
Apr-7 1.67 1.67 1.71 1.59

Coherus Oncology, Inc. Earnings

Data Unavailable

Coherus Oncology, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.04 per share, an increase this year of $0.60 per share, and a decrease next year of $0.02 per share.

* Coherus Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.